
Increasing hybridoma viability and antibody repertoire after the cell fusion by the use of human plasma as an alternative supplement
Keywords: FCS, fetal calf serum; HP, human plasma; GP, glycogen phosphorylase; BSA, bovine serum albumin; OVA, ovalbumin; CA, carbonic anhydrase; TI, trypsin inhibitor; LAC, lactalbumin.Human plasma; Fetal calf serum; Monoclonal antibody bank; Multiplexed antigen i